SCHEMBL24775784

SCHEMBL24775784

CC(C)(C)N1CCCC1c1ccccc1N1CCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.39
KEAP1 Q14145 1/20 0.39
MAPK1 P28482 2/20 0.38
EEF2K O00418 1/20 0.38
CHRNA7 P36544 2/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
RIPK1 Q13546 1/20 0.36
KCNQ2 O43526 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPC1 O15118 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24774527 0.97 CHRNA7 (0.37) GAAKEAP1MAPK1EEF2KCHRNA7
SCHEMBL24774538 0.90 ADRA2C (0.44) MAPK1CHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL24774537 0.90 RIPK1 (0.37) GAACHRNA7CHRNB2CHRNB4CHRNA3
SCHEMBL24774536 0.88 ADRB1 (0.46) KDM4EALDH1A1MAPT
SCHEMBL24775364 0.86 PDCD1 (0.35) GAACHRNA7MEN1KMT2AUSP2
SCHEMBL24774539 0.86 ALDH1A1 (0.35) GAAEEF2KCHRNA7CHRNB2CHRNB4
SCHEMBL24853468 0.86 OPRM1 (0.32) CHRNA7
SCHEMBL24774534 0.86 ROCK2 (0.39) MEN1KMT2A
SCHEMBL24774541 0.85 CHRNB2 (0.34) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL24775456 0.81 HSP90AA1 (0.44) CHRNA7CHRNB2CHRNB4CHRNA3CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402915-A1 BCL-2 INHIBITORS BEONE MEDICINES I GMBH (CH) 2022-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402915-A1 BCL-2 INHIBITORS BCL2, BCL2L1, BCL2L2 GAA 1765/4885KEAP1 1054/4885MAPK1 1202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.